Stocks
Black Diamond Therapeutics (BDTX) ROE US GAAP (year values) |
||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
| ROE, % | ? | 80.7% | 55.4% | 50.5% | 25.2% | -70.6% | -75.0% | |
| Changes by years, y/y, % | +23pp | -25pp | -5pp | -25pp | -96pp | |||
Black Diamond Therapeutics. ROE, %
Black Diamond Therapeutics. ROE, changes, pp
Black Diamond Therapeutics (BDTX) ROE US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| ROE, % | ? | -59.1% | -70.0% | -76.5% | -72.6% | -75.0% | -75.0% | |
| Changes by years, y/y, % | -177pp | -95pp | -99pp | +21pp | -16pp | |||
| Changes by quarters, q/q, % | +35pp | -11pp | -6pp | +4pp | -2pp | |||
